These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17093973)

  • 21. Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography.
    Rathore AS; Yu M; Yeboah S; Sharma A
    Biotechnol Bioeng; 2008 Jun; 100(2):306-16. PubMed ID: 18078292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biopharmaceutical production in plants: problems, solutions and opportunities.
    Gomord V; Chamberlain P; Jefferis R; Faye L
    Trends Biotechnol; 2005 Nov; 23(11):559-65. PubMed ID: 16168504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatographic purification of equine immunoglobulin G F(ab)2 from plasma.
    Fernandes A; Kaundinya JO; Daftary G; Saxena L; Banerjee S; Pattnaik P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(1):109-15. PubMed ID: 19008160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and quantification of affinity ligand leaching and specific antibody fragment concentration within chromatographic fractions using surface plasmon resonance.
    Thillaivinayagalingam P; Newcombe AR; O'Donovan K; Francis R; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2007 Dec; 48(Pt 4):179-88. PubMed ID: 17516918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput screening of chromatographic separations: I. Method development and column modeling.
    Coffman JL; Kramarczyk JF; Kelley BD
    Biotechnol Bioeng; 2008 Jul; 100(4):605-18. PubMed ID: 18496874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioseparation in antibody manufacturing: the good, the bad and the ugly.
    Gottschalk U
    Biotechnol Prog; 2008; 24(3):496-503. PubMed ID: 18442255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of and trends in the late-stage biopharmaceutical pipeline.
    Nagle PC; Nicita CA; Gerdes LA; Schmeichel CJ
    Am J Manag Care; 2008 Apr; 14(4):226-9. PubMed ID: 18402515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutical proteins: opportunities and challenges.
    Birch JR; Onakunle Y
    Methods Mol Biol; 2005; 308():1-16. PubMed ID: 16082021
    [No Abstract]   [Full Text] [Related]  

  • 29. Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances.
    Vicente T; Mota JP; Peixoto C; Alves PM; Carrondo MJ
    Biotechnol Adv; 2011; 29(6):869-78. PubMed ID: 21784144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time for an alternative perspective: the eternal problem of supply and quality of anti snake venom in the developing world--"it's the economy, stupid".
    Simpson ID
    Wilderness Environ Med; 2008; 19(3):186-94. PubMed ID: 18715131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Building biomanufacturing capacity--the chapter and verse.
    Kamarck ME
    Nat Biotechnol; 2006 May; 24(5):503-5. PubMed ID: 16680126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biopharma in Piedmont, Italy.
    Sakariassen KS
    Nat Rev Drug Discov; 2005 Jun; 4(6):519. PubMed ID: 15959953
    [No Abstract]   [Full Text] [Related]  

  • 33. Implementation of advanced technologies in commercial monoclonal antibody production.
    Zhou JX; Tressel T; Yang X; Seewoester T
    Biotechnol J; 2008 Oct; 3(9-10):1185-200. PubMed ID: 18759247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
    Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current and future issues in the manufacturing and development of monoclonal antibodies.
    Kozlowski S; Swann P
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):707-22. PubMed ID: 16828921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new liquid, intravenous immunoglobulin product (IGIV 10%) highly purified by a state-of-the-art process.
    Teschner W; Butterweck HA; Auer W; Muchitsch EM; Weber A; Liu SL; Wah PS; Schwarz HP
    Vox Sang; 2007 Jan; 92(1):42-55. PubMed ID: 17181590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process Analytical Technology (PAT): batch-to-batch reproducibility of fermentation processes by robust process operational design and control.
    Gnoth S; Jenzsch M; Simutis R; Lübbert A
    J Biotechnol; 2007 Oct; 132(2):180-6. PubMed ID: 17559961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput process development: determination of dynamic binding capacity using microtiter filter plates filled with chromatography resin.
    Bergander T; Nilsson-Välimaa K; Oberg K; Lacki KM
    Biotechnol Prog; 2008; 24(3):632-9. PubMed ID: 18454563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microtools for single-cell analysis in biopharmaceutical development and manufacturing.
    Love KR; Bagh S; Choi J; Love JC
    Trends Biotechnol; 2013 May; 31(5):280-6. PubMed ID: 23582471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data mining for rapid prediction of facility fit and debottlenecking of biomanufacturing facilities.
    Yang Y; Farid SS; Thornhill NF
    J Biotechnol; 2014 Jun; 179():17-25. PubMed ID: 24637375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.